CBS Executives Accused of Insider Trading

Securities Lawyers discuss insider trading accusations towards CBS executives. CBS CEO Les Moonves was forced to leave the company after numerous allegations of sexual misconduct came to light. Now Moonves is coming under fire again, facing new allegations of insider trading. A lawsuit filed recently claims that he and other CBS executives sold off massive amounts of CBS stock shortly before the sexual misconduct scandal became public.

The New Yorker published an exposé in July of 2018 detailing Moonves’ alleged misconduct, which included unwanted sexual advances, from the perspectives of six female employees. Moonves was terminated, and the company denied him his $120 million severance package. The report came shortly after similar allegations were levied against Roger Ailes at Fox News, forcing his departure from the network. The ouster of Ailes gave CBS’s stock a temporary boost, as the company touted its commitment to a zero-tolerance workplace. When the news about Moonves and the prevalence of sexual harassment at CBS became public, the stock price dropped dramatically.

Large Stock Transfers Timed to Avoid Drop in Price

In the months leading up to the release of the exposé on Moonves, he and three other CBS executives cashed in large amounts of stock, taking advantage of the inflated price. Combined, the four of them sold more than 3.4 million shares of stock totaling over $200 million in 2017 and early 2018. The timing of the sales raised suspicions for shareholders, who had already filed a lawsuit against the company after the exposé was released. The initial lawsuit claimed that CBS had deliberately misled shareholders in hiding the truth about its corporate culture.

Now a new complaint has been added to the original lawsuit. The complaint names Moonves and two of the other executives as defendants, alleging that the executives knew about the article and an ongoing LAPD investigation, and that they made the trades in anticipation of their effect on the company’s stock. Not only did they fail to disclose this information to shareholders, they also used it for their own personal gain in illegal trades. CBS has released a statement denying any wrongdoing, saying that most of the stock sales were part of existing selling arrangements and were compliant with securities laws. The others were pre-cleared by CBS and disclosed according to the law.

Companies are required to disclose information that could potentially impact their stock price. It is illegal for employees of a company to use non-public information to make trades. Whether or not the sales by CBS executives can be considered securities fraud depends on a number of factors, including how aware they were of the impending allegations at the time they made the trades and how far in advance they were scheduled.

Securities Lawyers at Shepherd, Finkelman, Miller & Shah, LLP Tackle Complex Investment-Related Disputes

The securities regulation lawyers at Shepherd, Finkelman, Miller & Shah, LLP have the knowledge and experience to handle all types securities fraud cases. Our lawyers understand the complexities of securities law and are committed to achieving the best possible outcome for clients. We provide comprehensive representation to clients nationwide. Call us today at 877-891-9880 or contact us online to discuss your case with an experienced securities lawyer.

A Message to Our Clients About Coronavirus COVID-19:

A Message to Our Clients About Coronavirus COVID-19

At Shepherd, Finkelman, Miller & Shah, LLP, we view the safety and well-being of our clients, staff and business partners as our highest priority.

The situation regarding the COVID-19 virus is continually changing, and we are following all recommended guidelines to stay healthy. As a result, our lawyers and staff are working remotely in accordance with the CDC's recommendations. We continue to work for all of our clients and are happy to arrange for phone or video consultations. We are also able to exchange documents via secure drives or email.

Please contact us online or call 866-540-5505 with any questions.

Thank you and take care.